Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Trademark usage description

biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific resea Read More

Classification Information

Class [001]
Biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific research and medical research; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for medical-scientific research use; chemicals for use in biotherapeutics, and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use.

Classification kind code

Class [005]
Medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and the prevention and treatment of rare diseases, namely, Cystic fibrosis, Methylmalonic acidemia, Propionic acidemia, Phenylketonuria, Ornithine transcarbamylase deficiency, Maple syrup urine disease, Arginase-1 deficiency, Factor VIII deficiency, Glycogen storage disorder type 1a, Adult-onset type II citrullinemia and Progressive familial intrahepatic cholestasis type; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents.

Classification kind code

Class [042]
Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, and therapeutic drugs; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids.

Classification kind code

Mark Details

Serial Number

2046804

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 10^th Dec 2021	Search Recorded
Submitted for opposition 20 on 10^th Dec 2021	Examiner's First Report
Submitted for opposition 223 on 10^th Dec 2021	Total Provisional Refusal
Submitted for opposition 48 on 25^th Jun 2021	Agent Changed
Submitted for opposition 256 on 21^st Jun 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 20^th Aug 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 20^th Aug 2020	Created
Submitted for opposition 31 on 20^th Aug 2020	Formalized
Submitted for opposition 30 on 10^th Jun 2020	Filed
Submitted for opposition 228 on 10^th Jun 2020	International Registration

MODERNA

Classification Information

Classification kind code

Classification kind code

Class [042]Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, and therapeutic drugs; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, and therapeutic drugs; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids.